• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传学与代谢重编程在胶质母细胞瘤中的相互作用:免疫抑制机制的新见解

Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms.

作者信息

Torrisi Filippo, D'Aprile Simona, Denaro Simona, Pavone Anna Maria, Alberghina Cristiana, Zappalà Agata, Giuffrida Rosario, Salvatorelli Lucia, Broggi Giuseppe, Magro Gaetano Giuseppe, Calabrese Vittorio, Vicario Nunzio, Parenti Rosalba

机构信息

Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, 95123 Catania, Italy.

Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, 95123 Catania, Italy.

出版信息

Antioxidants (Basel). 2023 Jan 18;12(2):220. doi: 10.3390/antiox12020220.

DOI:10.3390/antiox12020220
PMID:36829778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9952003/
Abstract

The central nervous system represents a complex environment in which glioblastoma adapts skillfully, unleashing a series of mechanisms suitable for its efficient development and diffusion. In particular, changes in gene expression and mutational events that fall within the domain of epigenetics interact complexly with metabolic reprogramming and stress responses enacted in the tumor microenvironment, which in turn fuel genomic instability by providing substrates for DNA modifications. The aim of this review is to analyze this complex interaction that consolidates several conditions that confer a state of immunosuppression and immunoevasion, making glioblastoma capable of escaping attack and elimination by immune cells and therefore invincible against current therapies. The progressive knowledge of the cellular mechanisms that underlie the resistance of the glioblastoma represents, in fact, the only weapon to unmask its weak points to be exploited to plan successful therapeutic strategies.

摘要

中枢神经系统是一个复杂的环境,胶质母细胞瘤能巧妙地适应其中,释放出一系列适合其高效发展和扩散的机制。特别是,属于表观遗传学领域的基因表达变化和突变事件与肿瘤微环境中发生的代谢重编程和应激反应复杂地相互作用,而肿瘤微环境又通过为DNA修饰提供底物来加剧基因组不稳定。本综述的目的是分析这种复杂的相互作用,这种相互作用巩固了几种导致免疫抑制和免疫逃逸状态的条件,使胶质母细胞瘤能够逃避免疫细胞的攻击和清除,因此对当前的治疗方法具有抗性。事实上,对胶质母细胞瘤耐药性背后细胞机制的逐步了解是揭示其弱点以制定成功治疗策略的唯一武器。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f03e/9952003/6124dd2ea2e5/antioxidants-12-00220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f03e/9952003/6124dd2ea2e5/antioxidants-12-00220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f03e/9952003/6124dd2ea2e5/antioxidants-12-00220-g001.jpg

相似文献

1
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms.表观遗传学与代谢重编程在胶质母细胞瘤中的相互作用:免疫抑制机制的新见解
Antioxidants (Basel). 2023 Jan 18;12(2):220. doi: 10.3390/antiox12020220.
2
Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.髓源性抑制细胞的代谢和功能重编程及其在胶质母细胞瘤中的治疗控制
Cell Stress. 2019 Jan 23;3(2):47-65. doi: 10.15698/cst2019.02.176.
3
Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro-inflammatory environment even in presence of glioblastoma cells.ONC201 对巨噬细胞的代谢和炎症重编程导致促炎环境的形成,即使在存在神经胶质瘤细胞的情况下也是如此。
Eur J Immunol. 2021 May;51(5):1246-1261. doi: 10.1002/eji.202048957. Epub 2021 Feb 5.
4
The network of immunosuppressive pathways in glioblastoma.胶质母细胞瘤中的免疫抑制通路网络。
Biochem Pharmacol. 2017 Apr 15;130:1-9. doi: 10.1016/j.bcp.2016.12.011. Epub 2016 Dec 22.
5
Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.胶质母细胞瘤中的代谢重编程:癌症代谢对表观遗传学的影响及未解决的问题
Neuro Oncol. 2016 Feb;18(2):160-72. doi: 10.1093/neuonc/nov125. Epub 2015 Jul 14.
6
mTORC2 in the center of cancer metabolic reprogramming.mTORC2处于癌症代谢重编程的核心位置。
Trends Endocrinol Metab. 2014 Jul;25(7):364-73. doi: 10.1016/j.tem.2014.04.002. Epub 2014 May 21.
7
The immunosuppressive microenvironment and immunotherapy in human glioblastoma.人类胶质母细胞瘤中的免疫抑制微环境与免疫疗法。
Front Immunol. 2022 Nov 17;13:1003651. doi: 10.3389/fimmu.2022.1003651. eCollection 2022.
8
Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma.胶质母细胞瘤代谢与免疫治疗中发现有效药物靶点的新策略
Curr Cancer Drug Targets. 2017;17(1):17-39. doi: 10.2174/1568009616666160512145436.
9
NOX4-Derived ROS Mediates TGF-1-Induced Metabolic Reprogramming during Epithelial-Mesenchymal Transition through the PI3K/AKT/HIF-1 Pathway in Glioblastoma.NOX4 产生的 ROS 通过 PI3K/AKT/HIF-1 通路介导 TGF-β1 诱导的上皮间质转化中的代谢重编程在脑胶质瘤中。
Oxid Med Cell Longev. 2021 Jun 27;2021:5549047. doi: 10.1155/2021/5549047. eCollection 2021.
10
Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived Lymphomas.B细胞淋巴瘤中免疫逃逸与代谢重编程的关联
Front Oncol. 2020 Nov 5;10:594782. doi: 10.3389/fonc.2020.594782. eCollection 2020.

引用本文的文献

1
The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities.胶质母细胞瘤免疫逃逸的代谢调控:从分子角度到治疗脆弱性
Cancers (Basel). 2025 Jun 4;17(11):1881. doi: 10.3390/cancers17111881.
2
Epigenetic reprogramming and antitumor immune responses in gliomas: a systematic review.胶质瘤中的表观遗传重编程与抗肿瘤免疫反应:一项系统综述
Med Oncol. 2025 May 16;42(6):213. doi: 10.1007/s12032-025-02760-y.
3
TAMing Gliomas: Unraveling the Roles of Iba1 and CD163 in Glioblastoma.

本文引用的文献

1
NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.NMDA 受体信号通过上调胶质母细胞瘤细胞中 MGMT 的表达诱导替莫唑胺耐药。
J Neurooncol. 2022 Nov;160(2):375-388. doi: 10.1007/s11060-022-04154-w. Epub 2022 Oct 29.
2
Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development.免疫调节信号网络和肿瘤免疫逃逸机制:临床开发中治疗靶点和药物的新见解。
Biochem J. 2022 Oct 28;479(20):2219-2260. doi: 10.1042/BCJ20210233.
3
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas.
靶向胶质瘤:揭示Iba1和CD163在胶质母细胞瘤中的作用
Cancers (Basel). 2025 Apr 26;17(9):1457. doi: 10.3390/cancers17091457.
4
The epigenetic mechanisms involved in the treatment resistance of glioblastoma.胶质母细胞瘤治疗耐药性涉及的表观遗传机制。
Cancer Drug Resist. 2025 Mar 13;8:12. doi: 10.20517/cdr.2024.157. eCollection 2025.
5
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance.将胶质母细胞瘤中的代谢重编程作为克服治疗抗性的新策略。
Front Cell Dev Biol. 2025 Feb 26;13:1535073. doi: 10.3389/fcell.2025.1535073. eCollection 2025.
6
Mechanisms and technologies in cancer epigenetics.癌症表观遗传学的机制与技术
Front Oncol. 2025 Jan 7;14:1513654. doi: 10.3389/fonc.2024.1513654. eCollection 2024.
7
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.一碳代谢在衰老过程中肿瘤进展中的关键作用。
Biomolecules. 2024 Oct 31;14(11):1387. doi: 10.3390/biom14111387.
8
The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential.胶质母细胞瘤中肿瘤相关巨噬细胞的双面战场:揭示其治疗潜力
Discov Oncol. 2024 Oct 25;15(1):590. doi: 10.1007/s12672-024-01464-5.
9
Effect of the Mediterranean Diet (MeDi) on the Progression of Retinal Disease: A Narrative Review.地中海饮食(MeDi)对视网膜疾病进展的影响:叙述性综述。
Nutrients. 2024 Sep 19;16(18):3169. doi: 10.3390/nu16183169.
10
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy.肿瘤相关中性粒细胞在恶性脑胶质瘤中的微环境调控:从机制到治疗。
J Neuroinflammation. 2024 Sep 16;21(1):226. doi: 10.1186/s12974-024-03222-4.
精氨酸琥珀酸裂解酶驱动胶质母细胞瘤中突变 TERT 启动子的激活。
Mol Cell. 2022 Oct 20;82(20):3919-3931.e7. doi: 10.1016/j.molcel.2022.09.024.
4
Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma.染色质重塑和分子异质性在胶质母细胞瘤治疗耐药中的作用
Cancers (Basel). 2022 Oct 9;14(19):4942. doi: 10.3390/cancers14194942.
5
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.探索胶质母细胞瘤干细胞异质性:免疫微环境调节与治疗机遇。
Front Oncol. 2022 Sep 21;12:995498. doi: 10.3389/fonc.2022.995498. eCollection 2022.
6
Critical role of lncEPAT in coupling dysregulated EGFR pathway and histone H2A deubiquitination during glioblastoma tumorigenesis.长非编码 RNA EPAT 在胶质母细胞瘤发生过程中连接失调的 EGFR 通路和组蛋白 H2A 去泛素化中的关键作用。
Sci Adv. 2022 Oct 7;8(40):eabn2571. doi: 10.1126/sciadv.abn2571. Epub 2022 Oct 5.
7
Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.多组学数据的综合分析鉴定了多形性胶质母细胞瘤的分子亚型和与氧化应激相关的预后生物标志物。
Oxid Med Cell Longev. 2022 Sep 22;2022:9993319. doi: 10.1155/2022/9993319. eCollection 2022.
8
The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies.脂质代谢在肿瘤免疫微环境中的作用及潜在治疗策略。
Front Oncol. 2022 Sep 12;12:984560. doi: 10.3389/fonc.2022.984560. eCollection 2022.
9
Exploring the role of Nrf2 signaling in glioblastoma multiforme.探索Nrf2信号通路在多形性胶质母细胞瘤中的作用。
Discov Oncol. 2022 Sep 28;13(1):94. doi: 10.1007/s12672-022-00556-4.
10
Epigenetic Suppression of the IL-7 Pathway in Progressive Glioblastoma.进展性胶质母细胞瘤中IL-7通路的表观遗传抑制
Biomedicines. 2022 Sep 2;10(9):2174. doi: 10.3390/biomedicines10092174.